Immunocore Holdings
Stock Forecast, Prediction & Price Target
Immunocore Holdings Financial Estimates
Immunocore Holdings Revenue Estimates
Immunocore Holdings EBITDA Estimates
Immunocore Holdings Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $26.52M N/A | $143.73M 441.99% | $249.42M 73.53% | Avg: $331.81M Low: $302.25M High: $392.69M avg. 33.03% | Avg: $356.20M Low: $328.82M High: $407.90M avg. 7.35% | Avg: $454.89M Low: $419.92M High: $520.92M avg. 27.70% | Avg: $666.00M Low: $614.80M High: $762.66M avg. 46.40% |
Net Income
% change YoY
| $-131.52M N/A | $-41.22M 68.65% | $-55.28M -34.11% | Avg: $-121.79M Low: $-129.23M High: $-37.06M avg. -120.29% | Avg: $-135.60M Low: $-197.08M High: $1.54M avg. -11.34% | Avg: $-45.58M Low: $-54.18M High: $-41.02M avg. 66.38% | Avg: $76.62M Low: $68.96M High: $91.07M avg. 268.09% |
EBITDA
% change YoY
| $-135.11M N/A | $-36.45M 73.02% | $-51.64M -41.67% | Avg: $-226.15M Low: $-267.64M High: $-206.01M avg. -337.89% | Avg: $-242.78M Low: $-278.01M High: $-224.11M avg. -7.35% | Avg: $-310.04M Low: $-355.04M High: $-286.21M avg. -27.70% | Avg: $-453.92M Low: $-519.81M High: $-419.03M avg. -46.40% |
EPS
% change YoY
| -$3.1 N/A | -$0.9 70.96% | -$1.13 -25.55% | Avg: -$1.9 Low: -$2.64 High: -$0.76 avg. -68.51% | Avg: -$2.04 Low: -$4.03 High: $0.03 avg. -7.07% | Avg: -$0.93 Low: -$1.11 High: -$0.84 avg. 54.27% | Avg: $1.57 Low: $1.41 High: $1.86 avg. 268.09% |
Operating Expenses
% change YoY
| $161.68M N/A | $182.89M 13.11% | $308.04M 68.42% | Avg: $517.95M Low: $471.81M High: $612.97M avg. 68.14% | Avg: $556.02M Low: $513.28M High: $636.73M avg. 7.35% | Avg: $710.07M Low: $655.49M High: $813.14M avg. 27.70% | Avg: $1.03B Low: $959.68M High: $1.19B avg. 46.40% |
FAQ
What is Immunocore Holdings stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 50.71% in 2025-2028.
We have gathered data from 13 analysts. Their low estimate is -129.23M, average is -121.79M and high is -37.06M.
What is Immunocore Holdings stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 28.62% in 2025-2028.
We have gathered data from 13 analysts. Their low revenue estimate is $302.25M, average is $331.81M and high is $392.69M.
What is Immunocore Holdings stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 61.69% in 2025-2028.
We have gathered data from 13 analysts. Their low earnings per share estimate is -$2.64, average is -$1.9 and high is $-0.75.
What is the best performing analyst?
In the last twelve months analysts have been covering Immunocore Holdings stock. The most successful analyst is David Dai.